Presented positive interim data for 4D-150 in wet age-related macular degeneration (wet AMD) from PRISM Phase 1/2 clinical trial highlighting robust and durable clinical activity across diverse patien ...

Take-Two Interactive CEO Strauss Zelnick has illuminated the company's position on AI tools and how they will be adopted for ...

BASEL, Switzerland I November 15, 2024 I Sandoz (SIX:SDZ/OTCQX:SDZNY), the global leader in generic and biosimilar medicines, today announced that the ...

The satirical website 'The Onion' has announced it has acquired the assets of Alex Jones' InfoWars website with the support ...

SOL-1 expected to be fully randomized by YE 2024 with topline data expected in Q4 2025 Active clinical trial sites now enrolling patients d ...

Vitamin C is a water-soluble vitamin needed for essential body processes. The human body does not make or store vitamin C, ...

Presented positive interim data for 4D-150 in wet age-related macular degeneration (wet AMD) from PRISM Phase 1/2 clinical trial highlighting ...

AMD patients referred to SpaMedica are offered an assessment within 14 days of referral SpaMedica is making eye health ...

Belite Bio, Inc. ( NASDAQ: BLTE) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Tom Lin - Chairman and Chief Executive Officer Hendrik Scholl - Chief Medical Officer Nathan Mata - Chief ...

Accumulation of toxic vitamin A byproducts (bisretinoids) has been implicated in the progression of GA ... in advanced dry age-related macular degeneration (AMD), in addition to specific metabolic ...

Dosed first patient in Phase 2/3 DRAGON II trial of Tinlarebant for the treatment of Stargardt disease (STGD1)Pivotal global Phase 3 PHOENIX ...